GE HealthCare PET/CT System Discovery MI DR High Resolution Imaging Low Dose Acquisition

Brand Name:GE HealthCare
Certification:ce
Model Number:Discovery™ MI DR
Minimum Order Quantity:1pcs
Delivery Time:10-15days
Payment Terms:L/C,T/T,Westen Union,Money Gram,Paypal/VTB
Contact Now

Add to Cart

Verified Supplier
Location: Chengdu China
Address: Jr Fantasia Tower B Of Mic Plaza Ii, No.1388 Middle Section Tianfu Avenue, High-Tech Zone, Chengdu China 610000
Supplier`s last login times: within 20 hours
Product Details Company Profile
Product Details

Description

The Discovery™ MI DR is a premium PET/CT system developed by GE Healthcare, designed to deliver exceptional molecular imaging capabilities combined with the flexibility of a standalone diagnostic CT. This all-digital platform aims to provide reproducible, high-quality results for complex clinical cases, supporting advancements beyond traditional FDG oncology studies into broader molecular imaging applications.
​​Core Advantages​​
  1. ​​All-Digital Molecular Imaging​​
    • Utilizes fully digital PET detector technology to enhance data acquisition and processing accuracy, enabling precise quantification of metabolic activity.
    • Improves sensitivity and spatial resolution for detecting subtle lesions, even in challenging cases.
  2. ​​Diagnostic CT Versatility​​
    • Functions as a standalone diagnostic CT system, allowing for detailed anatomical localization independent of PET acquisitions.
    • Supports comprehensive protocols for oncology, cardiology, neurology, and inflammatory diseases.
  3. ​​Workflow Efficiency and Clinical Expansion​​
    • Integrates deep learning-based software and analytics to streamline operational workflows, from patient scheduling to results communication.
    • Facilitates expansion into non-oncology areas (e.g., neurology, cardiology) with tailored imaging tracers.
  4. ​​Future-Ready Adaptability​​
    • Designed to accommodate evolving clinical needs, with modular hardware and software upgrades to align with emerging research and regulatory requirements.
    • Supports multi-tracer studies (beyond FDG) for personalized treatment monitoring.
​​Application Scenarios​​
  • ​​Oncology​​: Staging, restaging, and therapy response assessment for tumors.
  • ​​Cardiology​​: Evaluation of myocardial viability and inflammatory conditions.
  • ​​Neurology​​: Neurodegenerative disease research (e.g., Alzheimer’s) and epilepsy focus localization.
  • ​​Academic Medical Centers​​: Combines clinical service with research scalability for translational studies.
​​Technical Highlights​​
  • ​​System Type​​: Integrated PET/CT with standalone CT capability.
  • ​​Platform​​: All-digital data chain (detectors, processing, software).
  • ​​Key Innovation​​: Digital PET detectors for improved signal-to-noise ratio and quantitative accuracy.
  • ​​Compatibility​​: Supports GE’s analytics platforms for operational and financial optimization.
​​Brand Assurance​​
As part of GE Healthcare’s Discovery portfolio, the MI DR model reflects decades of expertise in molecular imaging, emphasizing reproducibility, clinical versatility, and institutional operational efficiency. Its design aligns with the industry shift toward digital precision medicine, offering a foundation for long-term growth in diagnostic and research capabilities.





China GE HealthCare PET/CT System Discovery MI DR High Resolution Imaging Low Dose Acquisition supplier

GE HealthCare PET/CT System Discovery MI DR High Resolution Imaging Low Dose Acquisition

Inquiry Cart 0